Legalization of Products Containing CBD? Not Quite Yet, Says FDA

Latham & Watkins LLP
Contact

The Agency plays a significant role in the evolving legal landscape governing certain cannabis-derived products.

Key Points:

..New law lifts or eases some, but not all, federal obstacles for certain cannabis-derived products.

..FDA’s authority to regulate cannabis-derived products is preserved, with existing laws prohibiting the marketing of foods and dietary supplements containing CBD remaining in place.

..FDA is actively exploring potential pathways to allow for the lawful marketing of such products either through issuance of new regulations or by requesting legislative action.

..Industry must keep abreast of expected regulatory developments and the possibility of legislative action.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide